LEADER 01605nam  2200385I  450 
001 9910711994103321
005 20190225105348.0
035   $a(CKB)5470000002488147
035   $a(OCoLC)1088412325
035   $a(EXLCZ)995470000002488147
100   $a20190225d2018      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPrescription opioids: medicare needs better information to reduce the risk of harm to beneficiaries $etestimony before the Subcommittee on Health Care, Committee on Finance, U.S. Senate /$f/ statement of Mary Denigan-Macauley
210  1$a[Washington, D.C.] :$cUnited States Government Accountability Office,$d2018.
215   $a1 online resource (13 pages) $ccolor illustrations
225 1 $aTestimony ;$vGAO-18-585T
300   $a"For release on delivery, expected at 1:00 p.m. ET, Tuesday, May 29, 2018."
320   $aIncludes bibliographical references.
517   $aPrescription opioids
606   $aOpioid abuse$zUnited States$xPrevention
606   $aMedication abuse$zUnited States$xPrevention
615  0$aOpioid abuse$xPrevention.
615  0$aMedication abuse$xPrevention.
702   $aDenigan-Macauley$b Mary
712 02$aUnited States.$bCongress.$bSenate.$bCommittee on Finance.$bSubcommittee on Health Care,
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910711994103321
996   $aPrescription opioids: medicare needs better information to reduce the risk of harm to beneficiaries$93503158
997   $aUNINA